British American Tobacco (BAT) is set to reveal its first half trading update on Tuesday, bringing into sharp focus its ambitious goal of transitioning to a predominantly smokeless business by 2035. As global attitudes towards smoking evolve and regulatory pressures mount, the tobacco giant’s strategic shift away from traditional cigarettes towards alternative products such as vapes and nicotine pouches becomes increasingly crucial.
A Shift in Strategy
For years, BAT has been adapting to changing consumer preferences, aiming to reduce its reliance on conventional cigarettes. The company’s recent statements underline its commitment to becoming a “predominately smokeless” entity by 2035. This mission reflects an industry-wide trend as tobacco firms grapple with stricter regulations and a declining acceptance of smoking in many parts of the world.
In 2025, smokeless products comprised approximately 18% of BAT’s total revenue. Despite significant sales from traditional cigarette brands like Lucky Strike, Pall Mall, and Dunhill, the company reported that cigarette sales reached £20.2 billion, while its newer product categories generated £3.6 billion. This indicates a growing interest in alternative products, with BAT claiming to attract millions of new customers annually to its smokeless lines.
Financial Forecast and Market Expectations
As BAT prepares for its trading update, it has indicated expectations for revenue growth between 3% and 5% for 2026, with its new category products projected to experience double-digit growth. Investors are keenly awaiting further insights into these projections, especially ahead of the company’s half-year results due on July 30.
Richard Hunter, head of markets at Interactive Investor, noted that BAT is strategically positioning itself to address the evolving landscape of smokeless products while simultaneously managing numerous challenges. He highlighted the increasing regulatory scrutiny on traditional tobacco sales, particularly aimed at protecting younger consumers, as a factor pressuring the company’s traditional market.
Navigating Ethical Concerns
The shift towards smokeless products also raises ethical questions among investors. As health concerns associated with tobacco use become more prominent, some investors hesitate to engage with the sector altogether. Hunter emphasised that this growing reluctance, paired with the decline in traditional product sales, underscores the importance of BAT’s transition strategy for attracting and retaining investment.
This ongoing evolution within the tobacco industry is not just about market share; it reflects a broader social awakening regarding health and well-being. As BAT works to navigate this complex environment, the investor community is closely monitoring its progress towards a smokeless future.
Why it Matters
The outcome of BAT’s transition strategy carries significant implications not just for the company but also for the wider tobacco industry and public health. As regulations tighten and consumer sentiment shifts, the success or failure of BAT’s smokeless initiative could set a precedent for how tobacco companies adapt to changing societal norms. Furthermore, it raises important conversations about the ethical dimensions of investing in tobacco-related businesses amidst growing health concerns. The decisions made today will resonate throughout the industry and impact future public health initiatives.
